Eurofins, FR0014000MR3

Eurofins stock: Goldman Sachs raises target to EUR 89.00 for Eurofins stock

Published on 10/19/2026 at 16:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eurofins will publish its nine-month update on October 21, 2026. Eurofins stock costs EUR 78.88 on October 19, 2026, 0.43 percent below its high.

Analyst target and trading dates

  • Goldman Sachs raised its 12-month Eurofins target to EUR 89.00 on October 6, 2026.
  • Eurofins will publish its nine-month update on October 21, 2026.
  • Eurofins stock costs EUR 78.88 at Lang & Schwarz on October 19, 2026 at 4:31 p.m. CEST, 0.43 percent below its 52-week high of EUR 79.22.
  • Eurofins trades at a P/E ratio of 27.53 as of October 19, 2026.
Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Goldman Sachs raised its 12-month price target for Eurofins from EUR 85.00 to EUR 89.00 on October 6, 2026, leaving the target 12.82 percent above the Lang & Schwarz price of EUR 78.88. The analyst view gives the stock a defined valuation marker ahead of Eurofins' next scheduled update. At Lang & Schwarz, Eurofins stock was trading at EUR 78.88 on October 19, 2026 at 4:31 p.m. CEST.

Target reaches EUR 89.00

According to Finvaulta, Goldman Sachs retained a Buy rating and lifted the target from EUR 85.00 to EUR 89.00. The report dated October 6, 2026 also forecasts 2.80 percent organic revenue growth for the third quarter and a 2.30 percent organic growth rate for fiscal year 2026. Those estimates are forecasts, not reported results.

Two dates shape the calendar

Eurofins will publish its nine-month update before markets open on October 21, 2026. The company also plans an investor event at its Amersfoort campus on October 23, 2026, according to its investor-relations page at Eurofins. The two dates give investors a near-term reporting milestone and a subsequent opportunity for management commentary.

Price stays below yearly high

Eurofins traded EUR 0.34 below its 52-week high of EUR 79.22 on October 19, 2026, a distance of 0.43 percent. The 52-week low was EUR 54.86, placing the current quote EUR 24.02 above that level. Trading volume stood at 75,332 shares against an average of 290,018 shares in the latest quote.

Valuation and peer lines

Eurofins had a market capitalization of EUR 13.7 billion and a P/E ratio of 27.53 as of October 19, 2026. Its trailing dividend yield was 1.00 percent. The latest H1 2026 investor update cited 130 basis points of adjusted EBITDA margin expansion and 29.00 percent earnings-per-share growth.

Comparison with peers

Eurofins: P/E 27.53, market capitalization EUR 13.7 billion
Vinci (Euronext Paris, EUR): minus 2.08 percent, P/E 11.74, market capitalization EUR 58.9 billion
Saint-Gobain (Euronext Paris, EUR): minus 1.26 percent, P/E 12.14, market capitalization EUR 32.1 billion.

Price and investor dates

The target distance, the upcoming October 21 update and the October 23 investor event define the next checkpoints for the stock. Eurofins' latest investor page also states that H1 2026 results were published on July 23, 2026.

The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.

Eurofins Scientific market details

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: ERF.PA
  • Price Lang & Schwarz as of October 19, 2026 at 4:31 p.m. CEST: EUR 78.88
  • Market capitalization: EUR 13.7 billion as of October 19, 2026
  • 52-week range: EUR 54.86-EUR 79.22 as of October 19, 2026
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report CAC 40.

More news and analyses on Eurofins stock

Disclaimer...
en | FR0014000MR3 | EUROFINS | boerse | 70363881 | bgmi